Bing Zhang

North Sichuan Medical University

Full Professor(heuristic)

Advanced Proteomics Techniques and Applications · Spectroscopy

h-index85

i10-index280

Publications775

Citations40,853

Grants

No NSF/NIH grants on record.

Lab Funding Health

Find elsewhere

Institution / lab homepage Search on ResearchGate

In-Field Influence

0.0484

PageRank within Spectroscopy co-authorship network

Explore collaboration map

Admission Signals

New paper: Integrated proteogenomic and metabolomic profiling of acute myeloid leukemias to identify molecular subtypes and associated therapy targets (Nature Cancer)2026-06-12
New preprint: Zuo Gui Wan Restores Bone Metabolism in Postmenopausal Osteoporosis through HIF-1 and PI3K–Akt Pathway Modulation: Evidence from UPLC– MS/MS and Network Analysis2025-11-13

Data Freshness

Publications as of 2026-07-01
Grants as of 2026-06-30

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

ORCID: 0000-0001-8676-2425

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 20 of 85

Integrated proteogenomic and metabolomic profiling of acute myeloid leukemias to identify molecular subtypes and associated therapy targets
Nature Cancer · 2026-06-12 · 1 citations
Enriched Metabolic Phenotyping Refines Phenotypic Resolution of Type 2 Diabetes
Diabetes Obesity and Metabolism · 2026-05-10
A 15-layer multi-omics analysis of gastric cancer ecotypes provides therapeutic insights
Cell Reports Medicine · 2026-04-20
Abstract PS1-09-14: Evaluating clinical and molecular correlates of Inflammatory Breast Cancer using a scoring system-based chart review
Clinical Cancer Research · 2026-02-17
FGFR1-Activated Translation of WNT Pathway Components with Structured 5′ UTRs Is Vulnerable to Inhibition of EIF4A-Dependent Translation Initiation
UNC Libraries · 2025-12-10
Targeting EIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer
UNC Libraries · 2025-12-09
Glymphatic Dysfunction Correlate with Spatial Navigation Deficits in Subjective Cognitive Decline: Insights from 5.0T MRI and Plasma Biomarkers Analysis
Alzheimer s & Dementia · 2025-12-01
Glymphatic system function associates with AD‐signature region volumes, plasma biomarkers, and white matter hyperintensity progression in cognitively unimpaired elderly
Alzheimer s & Dementia · 2025-12-01
Zuo Gui Wan Restores Bone Metabolism in Postmenopausal Osteoporosis through HIF-1 and PI3K–Akt Pathway Modulation: Evidence from UPLC– MS/MS and Network AnalysisPreprint
Research Square · 2025-11-13
Investigation of oil adsorption properties and mechanism with silanization and acetylation modified helianthus annuus straw
Marine Pollution Bulletin · 2025-11-05
Table S1 from Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast Cancer
2025-11-03
Figure S6 from Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast Cancer
2025-11-03
Table S2 from Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast Cancer
2025-11-03
Data from Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast Cancer
2025-11-03
Table S4 from Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast Cancer
2025-11-03
Figure S2 from Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast Cancer
2025-11-03
Table S3 from Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast Cancer
2025-11-03
Figure S1 from Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast Cancer
2025-11-03
Figure S3 from Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast Cancer
2025-11-03
Figure S5 from Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast Cancer
2025-11-03

Open author page on OpenAlex →